From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Suramin or suramin sodium is an antiparasitic drug normally used to treat an African neurological diaease often known as African trypanosomiasis or "Sleeping Sickness".[1] African trypanosomiasis is caused by the trypanosoma brucei parasite, and control effects reduced cases to around 2,000 per year by 2019.[1]

Side effects[edit | edit source]

Availability[edit | edit source]

Suramin is not commercially available in the United States or Canada.[2][1]

Evidence[edit | edit source]

Suramin is known to be effective for African trypanosomiasis.[1][2]

ME/CFS[edit | edit source]

Surami is being investigated as a treatment for ME/CFS.[3]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 Centers for Disease Control (March 9, 2020). "African Trypanosomiasis". Centers for Disease Control and Prevention. Retrieved September 26, 2020.
  2. 2.0 2.1 "Suramin Sodium Drug Information, Professional". Retrieved April 30, 2019.
  3. Open Medicine Foundation (September 5, 2017). "Deep Dive Into The Science On ME". Open Medicine Foundation. Retrieved April 30, 2019.